+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Orthopaedic Biomaterials Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • PDF Icon

    Report

  • 400 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 5926351
The global orthopaedic biomaterials market was valued at USD 22.75 Billion in 2024 driven by the increasing prevalence of orthopaedic diseases and musculoskeletal disorders across the globe. It is expected to grow at a CAGR of 7.50% during the forecast period of 2025-2034 and attain a market value of USD 46.89 Billion by 2034.

Orthopaedic Biomaterials Market Overview

Orthopaedic biomaterials are specific materials utilised in orthopaedic procedures to fix bones and joints. These materials are designed to imitate the mechanical characteristics of bone, offering stability and support while reducing negative responses. They play a vital role in joint replacements, fracture fixation, and spinal surgeries, improving patient results and extending the lifespan of implants. Surgeons choose appropriate materials based on the type of surgery and the patient's health, placing them either directly or as coatings on implants to improve their connection with nearby tissues.

Different kinds of orthopaedic biomaterials such as polymers, ceramics, bioactive glasses, calcium phosphate cement, and metals are selected for their distinct characteristics. Polymers are supple and light, while ceramics and biocompatible glasses offer strength and compatibility with the body. Calcium phosphate cement assists in bone regrowth, and metals offer resilience for implants that bear heavy loads. These biomaterials are utilized in medical facilities such as hospitals, specialized clinics, nursing homes, and outpatient surgical centers for surgeries like joint replacements and spinal fusions.

Orthopaedic Biomaterials Market Growth Drivers

Increasing Prevalence of Orthopedic Diseases and Musculoskeletal Problems Spurs Market Growth

The growth of the market is being fueled by the rising incidence of orthopaedic diseases and musculoskeletal issues like arthritis and fractures. The World Health Organization 2022 report showed that approximately 1.71 billion people globally are impacted by musculoskeletal problems because of population increase and aging. These issues are increasing causing a greater need for successful treatment options. Orthopaedic biomaterials are crucial in repairing tissues, aiding healing, and improving patients' quality of life.

Technological Advancements and Increasing Funding to Meet Rising Orthopaedic Biomaterials Market Demand

Advancements in technology and the rise in investments are promoting the expansion of the market. In July 2024, UK biotech firm 4D Medicine secured EUR 3.4 million worth of funding for its biomaterial technology geared towards orthopaedic products. The company will be able to finish pre-clinical testing and pursue FDA approval for its products. Advances in orthopaedic implants and devices have been enhanced by innovations such as 3D printing, nanotechnology, and bioengineering, resulting in the development of personalized, long-lasting, and biocompatible biomaterials. Government and private funding aid in research efforts, leading to the development of new materials such as biodegradable polymers and bioactive ceramics. These developments are broadening the use of biomaterials and driving market expansion.

Orthopaedic Biomaterials Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Increasing Geriatric Population

As people get older, they are more susceptible to orthopaedic problems such as osteoarthritis, leading to a higher demand for surgeries and implants made from cutting-edge biomaterials to enhance recovery and movement. Healthcare professionals are prioritizing the creation of new, inventive answers for age-related musculoskeletal issues, resulting in a rise in the need for specific orthopaedic biomaterials.

Rise in Sports-Related Injuries

The rise in sports participation has resulted in a notable surge in injuries such as ligament tears and fractures, prompting a demand for orthopaedic biomaterials that assist in tissue healing, joint support, and recovery. Healthcare professionals are concentrating on creating new ideas that benefit elderly patients as well as athletes, with the goal of improving patient results and enhancing quality of life.

Growing Demand for Biocompatible Materials

Biocompatible materials are crucial in orthopaedic applications as they enable implants and devices to seamlessly integrate with surrounding tissue, decreasing the likelihood of complications, and enhancing patient outcomes. Manufacturers are concentrating on creating advanced biomaterials that adhere to stringent biocompatibility standards to fulfill this requirement.

Increasing Use of Bioactive and Biodegradable Materials

There is a growing trend towards utilizing bioactive and biodegradable materials, which aid in healing, foster bone regeneration, and lessen the necessity for additional surgeries. These materials are becoming more popular because they improve patient care and support sustainable healthcare practices.

Orthopaedic Biomaterials Market Segmentation

Market Breakup by Material Type

  • Polymers
  • Ceramics & Bioactive Glasses
  • Calcium Phosphate Cement
  • Metal
  • Others

Market Breakup by Application

  • Orthobiologics
  • Joint Replacement/Reconstruction
  • Viscosupplementation
  • Orthopaedic Implants
  • Others

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Orthopaedic Biomaterials Market Share

Market Segmentation Based on the Material Type to Witness Growth

Based on material type, the market is divided into polymers, ceramics, bioactive glasses, calcium phosphate cement, metal, and others. Metals, such as titanium and stainless steel, are the preferred materials in orthopaedic biomaterials due to their strength, long-lasting properties, and compatibility with the body. These materials are perfect for supporting heavy loads in applications like joint replacements and spinal implants, as they can endure mechanical pressure and be tailored to match a patient's unique anatomy.

Orthopaedic Biomaterials Market Analysis by Region

Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

North America is expected to dominate the market powered by its advanced healthcare infrastructure, high research and development investments, and a significant prevalence of orthopaedic conditions. Regulatory authorities and substantial healthcare expenditures encourage the utilization of advanced biomaterials, while a shift towards minimally invasive and tailored treatments is driving market growth in the area.

In Europe, healthcare systems that are firmly established and growing expenses are boosting market share, fueled by the rising incidence of musculoskeletal disorders and a population that is getting older. Innovative solutions are being adopted due to regulatory frameworks and research collaboration that support market growth.

Increasing healthcare infrastructure, disposable incomes, and the growing prevalence of orthopaedic diseases drive significant market growth in the Asia Pacific region. Countries such as China and India are experiencing fast urban growth and expansion of the healthcare industry, resulting in a rise in the utilization of advanced biomaterials. Increased awareness and investments in research and development are setting the stage for significant market growth in the region.

Leading Players in the Orthopaedic Biomaterials Market

The key features of the market report include patent analysis, grant analysis, funding, and investment analysis as well as strategic initiatives by the leading players. The major companies in the market are as follows:

Evonik Industries AG

Evonik Industries AG is a German specialty chemicals company that offers a variety of products such as surfactants, polymers, resins, and additives. Their RESOMER Bioresorbable and VESTAKEEP PEEK Polymers are used to enhance orthopedic outcomes through temporary and permanent implant applications.

Depuy Synthes Inc.

DePuy Synthes is a medical device company under Johnson & Johnson, specializing in orthopaedic products and services such as trauma, joint reconstruction, spine, and sports medicine. Their products include the Attune revision knee system, SMARTSET and DePuy CMW bone cement, offering surgeons solutions for primary and revision knee procedures. Their bone cement is designed to meet the needs of today’s surgeons, with a portfolio including medium and high viscosity cement, plain or with gentamicin.

Zimmer Biomet

Zimmer Biomet Holdings is a publicly traded medical device company founded in 1927 in Warsaw, Indiana. They specialize in Trabecular Metal Technology, a highly porous biomaterial made from elemental tantalum with properties similar to bone, used in orthopaedic applications.

Matexcel

Matexcel is a leading provider of materials science services, offering a wide range of materials such as polymers, nanoparticles, metals, and ceramics to global customers from academia and industry. In September 2024, Matexcel expanded its hydroxyapatite product line, offering a variety of sizes and grades suited for research, medical, and food applications. Hydroxyapatite, a mineral vital to human health, is commonly used in biomedical applications like orthopaedic implants, dental implants, and bone regeneration therapies.

Other players in the market include DSM Biomedical, Stryker Corp, Invibo Ltd, Globus Medical, Exactech, Inc., AdvanSource Inc., Biomaterials Corp, Heraeus Holding Inc., and CAM Bioceramics B.V.

Key Questions Answered in the Orthopaedic Biomaterials Market Report

  • What was the global orthopaedic biomaterials market value in 2024?
  • What is the global orthopaedic biomaterials market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is the market segmentation based on material type?
  • What is the market segmentation based on end user?
  • What is the market breakup based on application?
  • What are the major factors aiding the global orthopaedic biomaterials market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the major drivers, opportunities, and restraints in the market?
  • What are the major trends influencing the market?
  • Which regional market is expected to dominate the market share in the forecast period?
  • Which country is likely to experience elevated growth during the forecast period?
  • Who are the key players involved in the global orthopaedic biomaterials market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Orthopaedic Biomaterials Market Overview
3.1 Global Orthopaedic Biomaterials Market Historical Value (2018-2024)
3.2 Global Orthopaedic Biomaterials Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Orthopaedic Biomaterials Market Landscape*
5.1 Global Orthopaedic Biomaterials Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Orthopaedic Biomaterials Market: Product Landscape
5.2.1 Analysis by Material Type
5.2.2 Analysis by Application
6 Global Orthopaedic Biomaterials Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Orthopaedic Biomaterials Market Segmentation (218-2034)
7.1 Global Orthopaedic Biomaterials Market (2018-2034) by Material Type
7.1.1 Market Overview
7.1.2 Polymers
7.1.3 Ceramics & Bioactive Glasses
7.1.4 Calcium Phosphate Cement
7.1.5 Metal
7.1.6 Others
7.2 Global Orthopaedic Biomaterials Market (2018-2034) by Application
7.2.1 Market Overview
7.2.2 Orthobiologics
7.2.3 Joint Replacement/Reconstruction
7.2.4 Viscosupplementation
7.2.5 Orthopaedic Implants
7.2.6 Others
7.3 Global Orthopaedic Biomaterials Market (2018-2034) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Specialty Clinics
7.3.4 Ambulatory Surgical Centers
7.3.5 Others
7.4 Global Orthopaedic Biomaterials Market (2018-2034) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Orthopaedic Biomaterials Market (218-2034)
8.1 North America Orthopaedic Biomaterials Market (2018-2034) by Material Type
8.1.1 Market Overview
8.1.2 Polymers
8.1.3 Ceramics & Bioactive Glasses
8.1.4 Calcium Phosphate Cement
8.1.5 Metal
8.1.6 Others
8.2 North America Orthopaedic Biomaterials Market (2018-2034) by Application
8.2.1 Market Overview
8.2.2 Orthobiologics
8.2.3 Joint Replacement/Reconstruction
8.2.4 Viscosupplementation
8.2.5 Orthopaedic Implants
8.2.6 Others
8.3 North America Orthopaedic Biomaterials Market (2018-2034) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Specialty Clinics
8.3.4 Ambulatory Surgical Centers
8.3.5 Others
8.4 North America Orthopaedic Biomaterials Market (2018-2034) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Orthopaedic Biomaterials Market (218-2034)
9.1 Europe Orthopaedic Biomaterials Market (2018-2034) by Material Type
9.1.1 Market Overview
9.1.2 Polymers
9.1.3 Ceramics & Bioactive Glasses
9.1.4 Calcium Phosphate Cement
9.1.5 Metal
9.1.6 Others
9.2 Europe Orthopaedic Biomaterials Market (2018-2034) by Application
9.2.1 Market Overview
9.2.2 Orthobiologics
9.2.3 Joint Replacement/Reconstruction
9.2.4 Viscosupplementation
9.2.5 Orthopaedic Implants
9.2.6 Others
9.3 Europe Orthopaedic Biomaterials Market (2018-2034) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Specialty Clinics
9.3.4 Ambulatory Surgical Centers
9.3.5 Others
9.4 Europe Orthopaedic Biomaterials Market (2018-2034) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Orthopaedic Biomaterials Market (218-2034)
10.1 Asia Pacific Orthopaedic Biomaterials Market (2018-2034) by Material Type
10.1.1 Market Overview
10.1.2 Polymers
10.1.3 Ceramics & Bioactive Glasses
10.1.4 Calcium Phosphate Cement
10.1.5 Metal
10.1.6 Others
10.2 Asia Pacific Orthopaedic Biomaterials Market (2018-2034) by Application
10.2.1 Market Overview
10.2.2 Orthobiologics
10.2.3 Joint Replacement/Reconstruction
10.2.4 Viscosupplementation
10.2.5 Orthopaedic Implants
10.2.6 Others
10.3 Asia Pacific Orthopaedic Biomaterials Market (2018-2034) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Specialty Clinics
10.3.4 Ambulatory Surgical Centers
10.3.5 Others
10.4 Asia Pacific Orthopaedic Biomaterials Market (2018-2034) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Orthopaedic Biomaterials Market (218-2034)
11.1 Latin America Orthopaedic Biomaterials Market (2018-2034) by Material Type
11.1.1 Market Overview
11.1.2 Polymers
11.1.3 Ceramics & Bioactive Glasses
11.1.4 Calcium Phosphate Cement
11.1.5 Metal
11.1.6 Others
11.2 Latin America Orthopaedic Biomaterials Market (2018-2034) by Application
11.2.1 Market Overview
11.2.2 Orthobiologics
11.2.3 Joint Replacement/Reconstruction
11.2.4 Viscosupplementation
11.2.5 Orthopaedic Implants
11.2.6 Others
11.3 Latin America Orthopaedic Biomaterials Market (2018-2034) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Specialty Clinics
11.3.4 Ambulatory Surgical Centers
11.3.5 Others
11.4 Latin America Orthopaedic Biomaterials Market (2018-2034) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Orthopaedic Biomaterials Market (218-2034)
12.1 Middle East and Africa Orthopaedic Biomaterials Market (2018-2034) by Material Type
12.1.1 Market Overview
12.1.2 Polymers
12.1.3 Ceramics & Bioactive Glasses
12.1.4 Calcium Phosphate Cement
12.1.5 Metal
12.1.6 Others
12.2 Middle East and Africa Orthopaedic Biomaterials Market (2018-2034) by Application
12.2.1 Market Overview
12.2.2 Orthobiologics
12.2.3 Joint Replacement/Reconstruction
12.2.4 Viscosupplementation
12.2.5 Orthopaedic Implants
12.2.6 Others
12.3 Middle East and Africa Orthopaedic Biomaterials Market (2018-2034) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Specialty Clinics
12.3.4 Ambulatory Surgical Centers
12.3.5 Others
12.4 Middle East and Africa Orthopaedic Biomaterials Market (2018-2034) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Grant Analysis
15.1 Analysis by Year
15.2 Analysis by Amount Awarded
15.3 Analysis by Issuing Authority
15.4 Analysis by Grant Product/Service
15.5 Analysis by Funding Institute
15.6 Analysis by Departments
15.7 Analysis by Recipient Organization
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Strategic Initiatives
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership and Collaborations
17.3 Analysis by Joint Ventures
17.4 Analysis by Leading Players
17.5 Analysis by Geography
18 Supplier Landscape
18.1 Market Share Analysis, By Region (Top 5 Companies)
18.2 DSM Biomedical
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Company News and Developments
18.2.5 Certifications
18.3 Evonik industries AG
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Company News and Developments
18.3.5 Certifications
18.4 Stryker Corp
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Company News and Developments
18.4.5 Certifications
18.5 Depuy Synthes Inc.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Company News and Developments
18.5.5 Certifications
18.6 Zimmer Biomet
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Company News and Developments
18.6.5 Certifications
18.7 Invibo Ltd
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Company News and Developments
18.7.5 Certifications
18.8 Globus Medical
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Company News and Developments
18.8.5 Certifications
18.9 Exactech, Inc.
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Company News and Developments
18.9.5 Certifications
18.10 Matexcel
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Company News and Developments
18.10.5 Certifications
18.11 AdvanSource Inc.
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Company News and Developments
18.11.5 Certifications
18.12 Biomaterials Corp.
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Company News and Developments
18.12.5 Certifications
18.13 CAM Bioceramics B.V.
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Company News and Developments
18.13.5 Certifications
18.14 Heraeus Holding Inc.
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Company News and Developments
18.14.5 Certifications
19 Global Orthopaedic Biomaterials Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Evonik Industries AG
  • Depuy Synthes Inc.
  • Zimmer Biomet
  • Matexcel

Table Information